Novavax Announces Expanded Collaboration and License Agreement with SK Bioscience for 40 Million…
Novavax, Inc. a biotechnology company developing next-generation vaccines for serious infectious diseases, and SK Bioscience, a vaccine business subsidiary of SK Group, announced an…
Read More...
Read More...
